The Implantable Medical Device Industry

The next factor to consider is competitive position and healthcare firms can substantially ensure higher quality of care when pricing there products and services at an increased level. Aside from pricing, cost is another major aspect since it can drastically affect a company’s competitive position. A hard investment would involve a MRI device that insurance companies or healthcare organizations could reimburse the office at a higher rate for providing the patients of improved cost-efficient results. As a result, such benefits accrue primarily from savings in drug expenditures, improved utilization of radiology tests, better capture of charges, and decreased billing errors, (Wang et al., 2003). Physician providers are always in competition with the latest and greatest technology, EMR system, and most effective medication for patients.

Each product must go through a progression of approval, clinical trials, and post market observation protocols in order to ensure its safety and effectiveness. Stages in the development of medical technologies are scientific background and development of idea for a product, product development, approval, and distribution, diffusion, adoption and utilization of the product. Health care professional, patients, families, and policy makers all struggle to understand how health is affected by behavior, economic and social

Competition between providers has caused physicians and hospitals to offer the most current healthcare technologies and modern, eye-catching settings has contributed to increasing healthcare costs, as well as providing unwarranted highly technical services (Shi & Singh, 2015). Renovations of the physical settings and the acquisition of expensive technologies elevated healthcare services prices to cover the additional costs of providing high technical services and attracting clients.

Many factors prompt the innovation of new technologies: Consumer demand, clinical accountability, medical advancements, research agendas, population health targets and the capacity and resources

In two of the diseases, coronary artery bypass graft surgery is better than angioplasty treatment. Coronary artery bypass is a surgery by using your vessels to repair the damaged arteries, but angioplasty treatment is using a human made tube to expand the damaged arteries. The benefits of coronary artery bypass surgery includes it has a lower death rate, especially among the “high risk” patients. And it’s reduced injury to the heart after the surgery. It’s a safe surgery to save our coronary arteries since it improves our survival rate and reduces the heart attack risk (benefits). However, angioplasty treatment has a risk after a long period of surgery. It helps to fix coronary artery disease at first for a short period. But after several years, your artery might start re-narrow or blocked again where your tube is hold, because of the blood clot clump together on the tube (risks). When a blood clot forms, it can block the artery to flow blood to heart (risks of angioplasty). It might cause heart attack or death. In conclusion, I personally prefer coronary artery bypass surgery than angioplasty

“An implanted Wearable Gadget Isn’t as Crazy as You’d Think” exists as an article written by Margaret Rhodes, and it dwells on a new technology that we could be wearing in the future similar to a tattoo but under our skin. In fact, New Deal Design calls the name of this new technology UnderSkin. Rhodes’ outlook on this technology stands that of an information type of article for its readers. Thus, what does Rhodes’ say about this new technology and where it is headed?

In Laura Cabrera’s journal article, “Human Implants: A Suggested Framework to Set Priorities”, Cabrera references many experts’ works in order to set a formal foundation of transhumanist knowledge for both the followers and skeptics of transhumanism, eventually bringing into light a much-ignored topic, technoethics. Finally, she clearly presents her logical approach in tackling the pressing questions technoethics brings regarding human implants, following a trend that others before her in the field of human bioenhancement have taken before, letting her work speak for itself and show the grave consequences technoethics entail and what they as a society could do to resolve it.

To diagnose a coronary artery disease (CAD) the doctor will use a coronary angiogram procedure to find the percentage of blockage or narrow in arteries, the angiogram results will help the doctor to decide a decision on patient treatment depends on the percentage of blockage on coronary artery, age, weight, and whether patients have other medical conditions, like diabetes . In cases with obstructive average a 50% or slightly more are treated by medications and Balloon angioplasty, but what about the cases with more than one artery completely blockage or the medication and stent do not help them? The doctor will choose a coronary artery bypass grafting surgery (CABG) to restore blood flow in the heart, CABG is a surgery done through replacement

Technological changes directly affect cost of treating a patient. These factors need to be properly explained to the patients so they can

Patients who suffer from mutivessel coronary artery disease have different treatments for their cases, there is no one perfect option, it depends on the patient condition or severity of the disease, or even patient's preference of the treatment after been told all the information about treatment options. To have clear idea about the different between coronary artery bypass grafting against percutaneous coronary interventions, I searched for articles, understood the different between the two of them, read the result of several studies then I determined my position regarding this debate. First the definitions of CABG and PCI:

Overview: Johnson & Johnson (J&J) operates in 265+ companies throughout 60+ countries, with a workforce of 126,500+ employees throughout three business segments (Johnson & Johnson, n.d.). From 2006-15, J&J’s total sales improved from $50.5 to $70.1 billion, and total net earnings climbed from $10.1 to $15.4 billion (Johnson & Johnson 1, n.d.). The medical device* segment amounted to 35.9 percent of 2015 total revenues (Johnson & Johnson 2015, n.d.). This analysis shall review the supply, demand, and market equilibrium, as well as production costs and the market structure, for an artificial hip implant.

The US medical device industry is the global leader with sales of around $136 billion, which represents approximately 45% of the global market, according to the US Government Accountability Office 2014 statistics. According to Espicom’s 2014 report, the

When I asked Dr. Marko about what he thinks will happen to implants in the future he stated: “I expect that it will expand.” He explained that “current DBS technologies are seeing expanding indications for more and more diseases with good results. But beyond this, there are whole new domains of brain implants coming online and in the research pipeline. These include the whole field of brain-computer interface, which allows the brain to control machines (e.g. prosthetic limbs). This is very promising, and some examples are already making it to real-world application. Additional implants designed to improve memory, etc. are also being developed. The future of those is less certain, but I suspect they will improve and start to see practical application as time goes on” [Marko].

In this study, the Assessment of The Last Advanced Non-Thrombogenic Angioplasty Stent (ATLANTA) enrolled 55 patients with:1) stable or unstable angina, 2) documentation of myocardial ischemia attributable to native coronary artery stenosis, 3)amenable to treatment by percutaneous stenting from May 2007 to August 2007.[1] The standards of enrollment are:1) patients age must between 30 to 70 years old with up to 2 de novo type A and/or B American Heart Association/ American College of Cardiology lesions to be treated with the Catania stent in a vessel with a reference diameter 2.5 and 3.5 mm by visual assessment.[1] This clinical study was completed based on Declaration of Helsinki. The Primary end points of this study are: Stent Thrombosis, non- target lesion revascularization, target lesion revascularization, target vessel revascularization, index vessel-related nonfatal myocardial infraction and cardiac death. Secondary end points are:

This report is written based on the case study of MedTech-Eletronics Equipment Manufacturer. The writer will introduce the background of the company and then list the problems it is facing which are waiting problems, material and capacity plans problems, quality control problems, inefficient operations problems and the problems of shop-floor systems and supplier systems. Then the study will discuss MPC and explain the 3 parts of MPC (Manufacturing Planning and Control) Framework which are front end, engine and back end. After that the essay will connect MPC and the 5 problems to find solutions which are production scheduling, engineering control, ISO 9000 or six sigma quality control systems, ICTs systems for communicating and just in time (JIT). Finally the writer will show the summary of this study.